David Alderman

David founded Molekule Consulting with an ethos of strategic and actionable competitive insight combined with client centricity. He is responsible for numerous engagements with varied scopes and objectives in competitive intelligence and primary market research areas. Project scopes range from pre-clinical through launch and lifecycle management (“LCM”) to supporting clients in clinical and commercial strategy development.

His major therapy expertise is in oncology, ophthalmology, cardiovascular, diabetes, autoimmune, and CNS. David attends numerous major medical congresses and scientific congresses globally.